Device-Assisted versus Standard Valsalva Maneuver for Terminating Supraventricular Tachycardia

Clinical Editorial

This randomized clinical trial assesses the efficacy of a handheld Valsalva maneuver assist device in improving sinus rhythm restoration rates in patients with supraventricular tachycardia.

Source Reference

Read the full original publication from the source journal or publisher link below.

Open Original Source More Feed Items

Related by Condition/Drug

PubMedRelated by Specialty

Laager Left Atrial Appendage Occlusion System: Prospective Multicenter Safety and Efficacy Study i

Cardiology • 24 Aug 2026

PubMedRelated by Specialty

Dynamic C‑reactive Protein Changes During Hospitalization Predict Adverse Events in Acute Type B I

Cardiology • 24 Aug 2026

medRxivRelated by Specialty

Normal Blood Volume Can Mask Abnormal RBC Mass or Plasma Volume in Heart Failure

Cardiology • 23 Aug 2026

medRxivRelated by Specialty

Stroke and Ischemic Heart Disease Trends in Western Sub‑Saharan Africa vs Global Progress, 1990–20

Cardiology • 23 Aug 2026

Med News TodayRelated by Specialty

Urolithin A from Pomegranate Precursors May Improve Heart Relaxation in HFpEF Models

Cardiology • 22 Aug 2026

AHA NewsRelated by Specialty

Amanda and Franklin Bass to Lead Heart of Hot Springs Campaign in Garland County

Cardiology • 21 Aug 2026